# ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE

> **NCT01772095** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 389 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia
- Cognitive Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01772095
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2014-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772095, "ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01772095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*